We are live on ! Find out more
CCC

Crescent Capital Consulting Portfolio holdings

AUM $607M
1-Year Est. Return 22.88%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+22.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$456M
AUM Growth
+$68.2M
Cap. Flow
+$50.3M
Cap. Flow %
11.02%
Top 10 Hldgs %
35.57%
Holding
570
New
94
Increased
158
Reduced
30
Closed
46
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VHT icon
26
Vanguard Health Care ETF
VHT
$18.2B
$4.89M 1.07%
21,385
+614
+3% +$141K
AAPL icon
27
Apple
AAPL
$4.52T
$4.85M 1.06%
39,721
+7,201
+22% +$924K
ESGV icon
28
Vanguard ESG US Stock ETF
ESGV
$13.6B
$4.68M 1.03%
63,449
+28,388
+81% +$2.06M
VONG icon
29
Vanguard Russell 1000 Growth ETF
VONG
$44.9B
$4.64M 1.02%
74,228
+7,396
+11% +$463K
IWN icon
30
iShares Russell 2000 Value ETF
IWN
$14.7B
$4.62M 1.01%
28,969
+9,015
+45% +$1.36M
KO icon
31
Coca-Cola
KO
$374B
$4.25M 0.93%
80,678
+39,620
+96% +$1.99M
IJS icon
32
iShares S&P Small-Cap 600 Value ETF
IJS
$8.41B
$4.18M 0.92%
41,471
+9,794
+31% +$927K
IJJ icon
33
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
$4.12M 0.9%
40,387
+7,872
+24% +$752K
IWS icon
34
iShares Russell Mid-Cap Value ETF
IWS
$16B
$3.99M 0.88%
36,485
+9,025
+33% +$940K
BSCN
35
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$3.86M 0.85%
177,356
+64,540
+57% +$1.41M
PG icon
36
Procter & Gamble
PG
$345B
$3.83M 0.84%
28,265
+86
+0.3% +$11.2K
GLD icon
37
SPDR Gold Trust
GLD
$132B
$3.65M 0.8%
22,792
-267
-1% -$44.9K
IBB icon
38
iShares Biotechnology ETF
IBB
$9.39B
$3.49M 0.77%
23,217
+3,349
+17% +$532K
MRK icon
39
Merck
MRK
$316B
$3.47M 0.76%
47,152
+1,812
+4% +$134K
JNJ icon
40
Johnson & Johnson
JNJ
$613B
$3.41M 0.75%
20,748
+1,296
+7% +$210K
LLY icon
41
Eli Lilly
LLY
$995B
$3.37M 0.74%
18,030
+2,817
+19% +$551K
DVYE icon
42
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$3.24M 0.71%
82,438
+81,956
+17,003% +$3.16M
XOM icon
43
ExxonMobil
XOM
$643B
$3.17M 0.7%
56,842
+27,713
+95% +$1.45M
AMZN icon
44
Amazon
AMZN
$2.99T
$3.12M 0.68%
20,180
+1,340
+7% +$212K
HD icon
45
Home Depot
HD
$339B
$3.05M 0.67%
9,993
+56
+0.6% +$15.4K
ACWI icon
46
iShares MSCI ACWI ETF
ACWI
$33.4B
$2.91M 0.64%
30,631
IWB icon
47
iShares Russell 1000 ETF
IWB
$49.9B
$2.75M 0.6%
12,314
-899
-7% -$197K
CVX icon
48
Chevron
CVX
$385B
$2.73M 0.6%
26,107
+4,729
+22% +$462K
CWB icon
49
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.77B
$2.45M 0.54%
29,374
-4,098
-12% -$354K
BMY icon
50
Bristol-Myers Squibb
BMY
$134B
$2.43M 0.53%
38,547
+1,899
+5% +$118K

Similar funds

Crescent Capital Consulting's Q1 2021 Portfolio in Review

As of Q1 2021, Crescent Capital Consulting held 570 positions worth $456M, up 18% from $388M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Crescent Capital Consulting deployed $50.3M of net new capital in Q1 2021, opening 94 new positions and adding to 158 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 20,297 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 5.4% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR Portfolio Mortgage Backed Bond ETF, an estimated $7.01M trimmed.

  • Crescent Capital Consulting's largest Q1 2021 buy was iShares MSCI ACWI ex US ETF: 20,297 shares worth $1.12M.
  • Crescent Capital Consulting added most to Invesco BulletShares 2022 High Yield Corporate Bond ETF in Q1 2021, an estimated $10.1M increase.
  • Crescent Capital Consulting's biggest Q1 2021 reduction was State Street SPDR Portfolio Mortgage Backed Bond ETF, cutting an estimated $7.01M.
  • Crescent Capital Consulting fully exited iShares GNMA Bond ETF in Q1 2021, selling an estimated $10.4M.
  • Crescent Capital Consulting's ten largest holdings make up 36% of its $456M portfolio in Q1 2021.
  • Crescent Capital Consulting opened 94 new positions and closed 46 in Q1 2021.
  • Crescent Capital Consulting's portfolio value rose 18% quarter-over-quarter to $456M.

Based on Crescent Capital Consulting's 13F filing for Q1 2021, filed 15 Apr 2021.